AMEX:RNN   REXAHN PHARMACEUTICALS INC
rnn
43 0 1
rnn
Consider this:
Several months back, this stock broke out with wholesale backing along with retail investor enthusiasm over several products in the pipeline with promising outlooks. Since then, .........news about ongoing trials with positive results to date. No bad news regarding any of the pipeline. IBB             correction along with most of the biotech sector in normal back and fill fashion.
Retail investors in somewhat of a dilemma apparently because the stock does not rise in a linear fashion. Wholesale investors still solid holders with what reads as a $1.05 type of basis.
Summary: Same fundamentals with the exception of good news on the ongoing pipeline studies. Retail investors selling, Professionals holding. Judging from minimal volume during sell, we can deduce retail paring of shares and resultant price declines.
I am long this stock for the same reasons I was earlier on.
Resultant huge price increases likely with favorable pipeline results.
Ideas Scripts Chart
United States
United Kingdom
India
España
Italia
Brasil
Россия
Türkiye
日本
한국
Home Stock Screener Economic Calendar How It Works Chart Features House Rules Moderators For the WEB Widgets Stock Charting Library Priority Support Feature Request Blog & News FAQ Help & Wiki Twitter
Private Messages Chat Ideas Published Followers Following Priority Support Public Profile Profile Settings Billing Sign Out